Compare Nippon India Pharma Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹100
Expense Ratio
1.85
2.19
NAV
₹599.20
₹44.45
Fund Started
10 May 2004
25 Jun 2018
Fund Size
₹8365.40 Cr
₹6668.95 Cr
Exit Load
Exit load of 1% if redeemed within 1 month.
Exit load of 1% if redeemed within 15 days.
1 Year
4.96%
5.68%
3 Year
21.76%
26.25%
5 Year
12.63%
15.27%
Equity
98.70%
96.76%
Cash
1.29%
3.24%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 13.85% |
Lupin Ltd. | 7.95% |
Dr. Reddy's Laboratories Ltd. | 7.04% |
Divi's Laboratories Ltd. | 6.61% |
Cipla Ltd. | 5.47% |
Apollo Hospitals Enterprise Ltd. | 5.01% |
Medplus Health Services Ltd. | 3.78% |
Vijaya Diagnostic Centre Ltd. | 3.36% |
Sai Life Sciences Ltd. | 3.27% |
Ajanta Pharma Ltd. | 3.19% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
10 May 2004
25 Jun 2018
